礼来Eli Lilly & Co. (LLY) 2006年年度报告「NYSE」.pdf

1、Eli Lilly and Company Lilly Corporate CenterIndianapolis,Indiana 46285 USAEli Lilly and Company2006 Annual Report,Notice of 2007 Annual Meeting,and Proxy StatementOn the CoverJackie WiseSpirit,a member of the Cahuilla Band,is president of the Board of Indian Health,Inc.,which offers programs for Nat

2、ive Americans suffering from diabetes and other diseases in Riverside and San Bernardino counties,in Califor-nia.She can identify with those shes working to help;Jackie was diagnosed with diabetes seven years agothe sixth of nine family members to have the disease.In 2006,her doctor recommended Byet

3、ta.Originally reluctant to take shots,she is delighted with the choice she made.“Now,I have so much more energy;my blood sugar is under control;Ive lost weight;and I feel good.In fact,all my friends say,You look great!”Byetta is a fi rst-in-class treatment for type 2 diabetes used in combination wit

4、h commonly prescribed oral medications that is a product of a collaboration between Lilly and Amylin Pharmaceuticals.Its glycemic control and association with most patients losing weight rather than gaining weight replace the vicious cycle so common in type 2 diabetes with a virtuous cycle.Because o

5、f its effect on people like Jackie,Byetta has become the fourth-most-prescribed branded pharmaceutical used to treat type 2 diabetes,measured by new prescriptions,in its fi rst full year on the market.2007 Eli Lilly and Company 2006ARFor More InformationLilly corporate Lilly clinical trials registry

6、 Multi-drug resistant tuberculosis initiative .www.lillymdr-Medicare prescription drug Pharmaceutical industry patient assistance programs.www.pparx.orgLilly C or call toll-free 1-800-545-6962TrademarksActos (pioglitazone hydrochloride)Alimta (pemetrexed disodium)Arxxant (ruboxistaurin mesylate)Axid